| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $227K | -22.0% | +427.9% |
| Cost of Revenue | $100K | -6.5% | +316.7% |
| Gross Profit | $127K | -31.0% | +568.4% |
| R&D Expense | $325K | -64.3% | — |
| SG&A Expense | $1.4M | +18.9% | -26.5% |
| Operating Income | -$1.6M | +16.5% | +15.1% |
| Pre-tax Income | -$1.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $96K | +11.6% | +700.0% |
| Current Assets | $565K | +42.3% | +81.1% |
| Total Assets | $6.2M | -3.7% | -5.6% |
| Current Liabilities | $4.8M | +22.6% | -7.4% |
| Total Liabilities | $4.8M | +22.2% | -7.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $3.4M | — | — |
| +6.9% |
| +14.5% |
| Income Tax | $0 | — | — |
| Net Income | -$1.7M | +6.9% | +14.5% |
| EPS (Basic) | -$0.05 | +16.7% | +37.5% |
| EPS (Diluted) | -$0.05 | +16.7% | +37.5% |
| $1.4M |
| -44.1% |
| +1.2% |